Introduction
Mindray's enzymatic HbA1c solution has achieved a remarkable milestone by becoming the first Chinese brand listed on the NGSP (National Glycohemoglobin Standardization Program) website for its exceptional anti-variant interference capabilities. This recognition underscores Mindray's commitment to advancing diabetes care through innovative solution.
Key Highlight
NGSP Recognition
Mindray's enzymatic HbA1c solution has successfully passed the stringent NGSP certification, ensuring accurate and reliable HbA1c measurement even in the presence of common hemoglobin variants.
?
Anti-Variant Interference
Mindray uses enzymatic method for chemistry HbA1c test, in which the enzymatic protease cleavage occurs before the location of the amino acid substitution for these variants, ensuring its excellent anti-variant interference capabilities.
Mindray's Comprehensive Chemistry HbA1c Solution
Whole-blood HbA1c, easy operation:
Whole-blood sample onboard hemolysis without manual pretreatment.
Accurate result, traceable to international standards:
Excellent accuracy and precision with bias <3% and CV <2%, and excellent correlation coefficient between Mindray model and Tosoh G8, Roche c501.
Less rerun-rate for anemia sample:
Evaluates hemoglobin (Hb) concentration during the hemolysis process and initiates sample increment tests in advance for low-Hb concentration samples. (e.g., anemia).
Conclusion
Mindray's inclusion in the NGSP anti-variant interference list shows its reliability in HbA1c testing and further diabetes diagnostics. By providing reliable and innovative solution, Mindray continues to support healthcare professionals in their e orts to combat diabetes, ensuring better patient outcomes globally.
Resources
NGSP website: https://ngsp.org/factors.asp
Analytical performance evaluation of the Mindray enzymatic assay for hemoglobin A1c measurement:?https://www.nature.com/articles/s41598-024-63261-y
